In vitro susceptibility of Mycobacterium tuberculosis to fusidic acid

Clinical Microbiology and Infection

Volumn 7, Issue 12, 2001, Pages 700-702

  Cicek Saydam, C ^a   Cavusoglu, C ^a   Burhanoglu, D ^a   Hilmioglu, S ^a   Ozkalay, N ^a   Bilgic, A ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; FUSIDIC ACID; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; IN VITRO STUDY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0035746999     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2001.00341.x     Document Type: Article

References (9)

1. Susceptibility of strains of the Mycobacterium tuberculosis complex to fusidic acid
2. Drug-resistance of Mycobacterium tuberculosis in time
3. The clinical use of fluoroquinolones for the treatment of mycobacterial disease
4. Comparative in vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp
5. Public Health Mycobacteriology. A Guide for the Level III Laboratory
6. Antimicrobial Susceptibility Testing for Mycobacterium Tuberculosis
7. The pharmacokinetics of fusidic acid
8. Susceptibility of mycobacteria to fusidic acid
9. Antituberculosis Drug Resistance in the World. The WHO/IUATLD Global Project on Antituberculosis Drug Resistance Surveillance 1994-97